These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis. Kobayashi S, Ohnuma N, Yoshida H, Ohtsuka Y, Terui K, Asano T, Ryu M, Ochiai T. Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715 [Abstract] [Full Text] [Related]
6. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union. Jung YS, Lee KJ, Kim H, Kim WH, Kim IG, Yoo BM, Kim JH, Kim MW. Hepatogastroenterology; 2004 Jan; 51(58):946-9. PubMed ID: 15239220 [Abstract] [Full Text] [Related]
18. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. Tashiro S, Imaizumi T, Ohkawa H, Okada A, Katoh T, Kawaharada Y, Shimada H, Takamatsu H, Miyake H, Todani T, Committee for Registration of the Japanese Study Group on Pancreaticobiliary Maljunction. J Hepatobiliary Pancreat Surg; 2003 Jan; 10(5):345-51. PubMed ID: 14598134 [Abstract] [Full Text] [Related]
19. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Chijiiwa K, Kimura H, Tanaka M. Int Surg; 1995 Jan; 80(1):61-4. PubMed ID: 7657495 [Abstract] [Full Text] [Related]
20. Incidence of anomalous union of the pancreaticobiliary ductal system in biliary cancer. Sandoh N, Shirai Y, Hatakeyama K. Hepatogastroenterology; 1997 Jan; 44(18):1580-3. PubMed ID: 9427026 [Abstract] [Full Text] [Related] Page: [Next] [New Search]